{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:06:55Z","timestamp":1771852015877,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570123"],"award-info":[{"award-number":["81570123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00277-021-04710-w","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T13:02:51Z","timestamp":1641474171000},"page":"359-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of KIAA1191 in the necroptotic pathway of multiple myeloma"],"prefix":"10.1007","volume":"101","author":[{"given":"Zhao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-6606","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"10","key":"4710_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.6004\/jnccn.2019.0049","volume":"17","author":"SK Kumar","year":"2019","unstructured":"Kumar SK, Callander NS, Hillengass J et al (2019) NCCN guidelines insights: multiple myeloma, Version 1.2020. J Natl Compr Canc Netw. 17(10):1154\u20131165","journal-title":"J Natl Compr Canc Netw."},{"issue":"12","key":"4710_CR2","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538\u2013e548","journal-title":"Lancet Oncol"},{"issue":"14","key":"4710_CR3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1200\/JCO.18.02096","volume":"37","author":"J Mikhael","year":"2019","unstructured":"Mikhael J, Ismaila N, Cheung MC et al (2019) Treatment of multiple myeloma: ASCO and CCO Joint Clinical Practice Guideline. J Clin Oncol 37(14):1228\u20131263","journal-title":"J Clin Oncol"},{"issue":"15","key":"4710_CR4","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San MJ, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412\u20133420","journal-title":"J Clin Oncol"},{"issue":"26","key":"4710_CR5","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S et al (2015) Revised International Staging System for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol 33(26):2863\u20132869","journal-title":"J Clin Oncol"},{"key":"4710_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.aca.2013.01.005","volume":"768","author":"P Teppola","year":"2013","unstructured":"Teppola P, Taavitsainen VM (2013) Parsimonious and robust multivariate calibration with rational function least absolute shrinkage and selection operator and rational function elastic net. Anal Chim Acta 768:57\u201368","journal-title":"Anal Chim Acta"},{"issue":"2","key":"4710_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1037\/a0027127","volume":"17","author":"SI Vrieze","year":"2012","unstructured":"Vrieze SI (2012) Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychol Methods 17(2):228\u2013243","journal-title":"Psychol Methods"},{"key":"4710_CR8","doi-asserted-by":"publisher","first-page":"103496","DOI":"10.1016\/j.jbi.2020.103496","volume":"108","author":"E Longato","year":"2020","unstructured":"Longato E, Vettoretti M, Di Camillo B (2020) A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models. J Biomed Inform. 108:103496","journal-title":"J Biomed Inform."},{"issue":"6","key":"4710_CR9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek J, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW (2018) Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol 74(6):796\u2013804","journal-title":"Eur Urol"},{"issue":"14","key":"4710_CR10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, McGinn T, Guyatt G (2017) Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA 318(14):1377\u20131384","journal-title":"JAMA"},{"issue":"2","key":"4710_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.7326\/M13-1522","volume":"160","author":"MJ Leening","year":"2014","unstructured":"Leening MJ, Vedder MM, Witteman JC, Pencina MJ, Steyerberg EW (2014) Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician\u2019s guide. Ann Intern Med 160(2):122\u2013131","journal-title":"Ann Intern Med"},{"issue":"4","key":"4710_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/CIRCIMAGING.113.000797","volume":"6","author":"TD Miller","year":"2013","unstructured":"Miller TD, Askew JW (2013) Net reclassification improvement and integrated discrimination improvement: new standards for evaluating the incremental value of stress imaging for risk assessment. Circ Cardiovasc Imaging 6(4):496\u2013498","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"4710_CR13","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1038\/s41598-017-07964-5","volume":"7","author":"PP Xu","year":"2017","unstructured":"Xu PP, Sun YF, Fang Y, Song Q, Yan ZX, Chen Y, Jiang XF, Fei XC, Zhao Y, Leboeuf C, Li B, Wang CF, Janin A, Wang L, Zhao WL (2017) JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide. Sci Rep 7(1):7433","journal-title":"Sci Rep"},{"issue":"6","key":"4710_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/leu.2011.357","volume":"26","author":"P Liu","year":"2012","unstructured":"Liu P, Xu B, Shen W, Zhu H, Wu W, Fu Y, Chen H, Dong H, Zhu Y, Miao K, Xu W, Li J (2012) Dysregulation of TNF alpha-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1. Leukemia 26(6):1293\u20131300","journal-title":"Leukemia"},{"issue":"2","key":"4710_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","volume":"22","author":"DE Christofferson","year":"2010","unstructured":"Christofferson DE, Yuan J (2010) Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22(2):263\u2013268","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"4710_CR16","doi-asserted-by":"publisher","first-page":"e1299302","DOI":"10.1080\/2162402X.2017.1299302","volume":"6","author":"G Stoll","year":"2017","unstructured":"Stoll G, Ma Y, Yang H, Kepp O, Zitvogel L, Kroemer G (2017) Pro-necrotic molecules impact local immunosurveillance in human breast cancer. Oncoimmunology. 6(4):e1299302","journal-title":"Oncoimmunology."},{"key":"4710_CR17","doi-asserted-by":"publisher","first-page":"e1636","DOI":"10.1038\/cddis.2015.16","volume":"6","author":"K Moriwaki","year":"2015","unstructured":"Moriwaki K, Bertin J, Gough PJ, Orlowski GM, Chan FK (2015) Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death. Cell Death Dis. 6:e1636","journal-title":"Cell Death Dis."},{"issue":"1","key":"4710_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","volume":"30","author":"U Hockendorf","year":"2016","unstructured":"Hockendorf U, Yabal M, Herold T et al (2016) RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer Cell 30(1):75\u201391","journal-title":"Cancer Cell"},{"key":"4710_CR19","doi-asserted-by":"publisher","first-page":"e1884","DOI":"10.1038\/cddis.2015.240","volume":"6","author":"P Geserick","year":"2015","unstructured":"Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, Gough PJ, Feoktistova M, Leverkus M (2015) Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis. 6:e1884","journal-title":"Cell Death Dis."},{"issue":"5","key":"4710_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/carcin\/bgw032","volume":"37","author":"KD McCormick","year":"2016","unstructured":"McCormick KD, Ghosh A, Trivedi S, Wang L, Coyne CB, Ferris RL, Sarkar SN (2016) Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma. Carcinogenesis 37(5):522\u2013529","journal-title":"Carcinogenesis"},{"issue":"7","key":"4710_CR21","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1158\/0008-5472.CAN-08-4079","volume":"69","author":"S Park","year":"2009","unstructured":"Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, Zhao D, Bachoo RM, Pieper RO, Habib AA (2009) The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res 69(7):2809\u20132816","journal-title":"Cancer Res"},{"issue":"9","key":"4710_CR22","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/carcin\/bgt143","volume":"34","author":"Q Wang","year":"2013","unstructured":"Wang Q, Chen W, Xu X, Li B, He W, Padilla MT, Jang JH, Nyunoya T, Amin S, Wang X, Lin Y (2013) RIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen species. Carcinogenesis 34(9):2119\u20132128","journal-title":"Carcinogenesis"},{"issue":"2","key":"4710_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114(2):181\u2013190","journal-title":"Cell"},{"issue":"7","key":"4710_CR24","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cell.2008.10.044","volume":"135","author":"J Hitomi","year":"2008","unstructured":"Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J (2008) Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135(7):1311\u20131323","journal-title":"Cell"},{"issue":"6","key":"4710_CR25","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137(6):1100\u20131111","journal-title":"Cell"},{"issue":"6","key":"4710_CR26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137(6):1112\u20131123","journal-title":"Cell"},{"issue":"3","key":"4710_CR27","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/10428194.2013.809077","volume":"55","author":"W Wu","year":"2014","unstructured":"Wu W, Zhu H, Fu Y, Shen W, Xu J, Miao K, Hong M, Xu W, Liu P, Li J (2014) Clinical significance of down-regulated cylindromatosis gene in chronic lymphocytic leukemia. Leuk Lymphoma 55(3):588\u2013594","journal-title":"Leuk Lymphoma"},{"issue":"1\u20132","key":"4710_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11010-010-0690-4","volume":"350","author":"M Mishra","year":"2011","unstructured":"Mishra M, Inoue N, Heese K (2011) Characterizing the novel protein p33MONOX. Mol Cell Biochem 350(1\u20132):127\u2013134","journal-title":"Mol Cell Biochem"},{"issue":"18","key":"4710_CR29","doi-asserted-by":"publisher","first-page":"14863","DOI":"10.1074\/jbc.M111.288670","volume":"287","author":"L Duprez","year":"2012","unstructured":"Duprez L, Bertrand MJ, Vanden BT, Dondelinger Y, Festjens N, Vandenabeele P (2012) Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. J Biol Chem 287(18):14863\u201314872","journal-title":"J Biol Chem"},{"issue":"1","key":"4710_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1600-065X.2012.01104.x","volume":"246","author":"T Gantke","year":"2012","unstructured":"Gantke T, Sriskantharajah S, Sadowski M, Ley SC (2012) IkappaB kinase regulation of the TPL-2\/ERK MAPK pathway. Immunol Rev 246(1):168\u2013182","journal-title":"Immunol Rev"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04710-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04710-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04710-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T09:04:53Z","timestamp":1641632693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04710-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4710"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04710-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Review Board of Zhongshan Hospital of Fudan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}